curable STIs were treated. Females had a higher prevalence of all pathogens at both visits (p<0.001 for all, Abstract O1-S04.05 table 1). Overall annual incidence rates (per 1,000, 95% CI), based on results of the 934 (96%) students who attended the 42M/54M visits (934 urine, 931 serology tests), were substantially higher in females compared to males [males: GC 18.4 (8.7e36.6) Background We conducted a prospective study to confirm our impression that incarcerated adolescents sometimes developed pelvic inflammatory disease (PID) during the brief interval between testing and treatment for gonorrhoeal and chlamydial cervicitis. Methods We performed the study at the Harris County Juvenile Detention Center, Texas, where PID in females is relatively common and where the prevalence of gonorrhoea and chlamydia infections is high. At the time of their mandated medical assessment, all incarcerated adolescents submitted first-catch urine samples for chlamydia and gonorrhoea testing. We used Gen-Probe NAAT assays. If at the time of testing a patient had symptoms suggestive of PID, we performed a bimanual pelvic examination and treated those who met the criteria for PID. For the diagnosis of PID, we used the criteria of the US Centers for Disease Control and Prevention: the presence of adnexal or cervical motion or uterine tenderness. The pelvic examinations were performed by one of three experienced physicians. For the patients who did not have PID at the time of testing, we reassessed them when we learnt that their urine test was positive. The tests were run in batches by the city health department, so that a variable length of time elapsed between the day of testing and the day that we received test results. At re-assessment, patients received a PID diagnosis if they had lower abdominal pain and met the PID diagnostic criteria on bimanual pelvic examination. Results We evaluated 99 subjects between 29 March 2010 and 27 December 2010. Their mean age was 15.8 (SD 1.1) years. Their race/ ethnicity was 43% black, 32% Hispanic, and 25% white; 74% had chlamydia, 14% gonorrhoea, and 12% both. The interval between testing and treatment ranged from 2 to 17 days; the mean (SD) was 7.5 (2.9) days. During this interval, 13 of 99 (13%) developed lower abdominal pain and had bimanual pelvic examination findings that supported the diagnosis of PID. Of these 13, 10 (77%) had chlamydia, 2 (15%) had gonorrhoea, and 1 (8%) had both infections. Time from initial urine testing to treatment for PID ranged from 7 to 15 days. Conclusion In incarcerated adolescents infected with gonorrhoea and/or chlamydia, a surprisingly large proportion (13%) developed PID during the brief period between testing and treatment.
Background We conducted a prospective study to confirm our impression that incarcerated adolescents sometimes developed pelvic inflammatory disease (PID) during the brief interval between testing and treatment for gonorrhoeal and chlamydial cervicitis. Methods We performed the study at the Harris County Juvenile Detention Center, Texas, where PID in females is relatively common and where the prevalence of gonorrhoea and chlamydia infections is high. At the time of their mandated medical assessment, all incarcerated adolescents submitted first-catch urine samples for chlamydia and gonorrhoea testing. We used Gen-Probe NAAT assays. If at the time of testing a patient had symptoms suggestive of PID, we performed a bimanual pelvic examination and treated those who met the criteria for PID. For the diagnosis of PID, we used the criteria of the US Centers for Disease Control and Prevention: the presence of adnexal or cervical motion or uterine tenderness. The pelvic examinations were performed by one of three experienced physicians. For the patients who did not have PID at the time of testing, we reassessed them when we learnt that their urine test was positive. The tests were run in batches by the city health department, so that a variable length of time elapsed between the day of testing and the day that we received test results. At re-assessment, patients received a PID diagnosis if they had lower abdominal pain and met the PID diagnostic criteria on bimanual pelvic examination. Results We evaluated 99 subjects between 29 March 2010 and 27 December 2010. Their mean age was 15.8 (SD 1.1) years. Their race/ ethnicity was 43% black, 32% Hispanic, and 25% white; 74% had chlamydia, 14% gonorrhoea, and 12% both. The interval between testing and treatment ranged from 2 to 17 days; the mean (SD) was 7.5 (2.9) days. During this interval, 13 of 99 (13%) developed lower abdominal pain and had bimanual pelvic examination findings that supported the diagnosis of PID. Of these 13, 10 (77%) had chlamydia, 2 (15%) had gonorrhoea, and 1 (8%) had both infections. Time from initial urine testing to treatment for PID ranged from 7 to 15 days. Conclusion In incarcerated adolescents infected with gonorrhoea and/or chlamydia, a surprisingly large proportion (13%) developed PID during the brief period between testing and treatment. Background Several bacterial candidate organisms (COs) have recently been shown to be highly specific for BV. The epidemiological profiles for these COs are unknown and no studies have examined COs in young sexually-inexperienced women, whether these COs are sexually-transmitted, or how they relate to specific sexual activities. Methods This study incorporates two study populations: The Female University Student Study which recruited women aged 17e21 years attending the University of Melbourne, and a sexuallyexperienced clinic population from Melbourne Sexual Health Centre. Participants completed a questionnaire addressing demographics and detailed sexual practices. Gram-stained vaginal smears Abstract O1-S04.05 Table 1 Prevalence and incidence data for East London students. (Note: Blood testing was declined by 2 students at 42 months and 4 youth and 54 months. Data were missing on vaginal intercourse for a further 3 students at 54 months) Objectives (1) To identify correlates of incident Bacterial vaginosis (BV) among high-risk women and (2) to identify predictors of discordance between self-reported lack of semen exposure in the past 6 months and the detection of spermatozoa on Gram stain, which provides biological evidence of recent exposure. Methods Analyses were based on among 871 HIV-infected and 439 HIV-uninfected women participating in HIV Epidemiology Research Study (HERS) which was conducted in 4 sites in the US Participants completed study visits conducted at baseline and at 6-month intervals thereafter. We conducted both cohort and casecrossover analyses, stratified by HIV infection status, to evaluate potential correlates of incident BV. We also used logistic regression to identify predictors of discordance between self-reported lack of exposure to semen and the detection of spermatozoa on Gram stain. Results BV incidence was 21% among HIV-infected women and 19% among HIV-uninfected women. We found fewer correlates of incident BV when assessed with a case-crossover design than with a cohort design. Reporting frequent coitus (regardless of consistency of condom use) was correlated with incident BV in the cohort analyses but not in the case-crossover analyses. The sole correlate that emerged in both the cohort and case-crossover analyses among HIV-infected and -uninfected women was the detection of spermatozoa on Gram stain. Seven factors were associated with discordance between self-reported semen exposure and spermatozoa detection in the multivariable analysis. Discordance differed by study site and race/ethnicity and was more common among younger women. The following infections or conditions also were predictive of discordance: HIV (adjusted OR [aOR], 2.8; 95% CI, 1.7% to 4.6%), BV (aOR, 1.9; 95% CI, 1.5% to 2.5%), and human papillomavirus (aOR, 1.3; 95% CI, 1.0% to 1.8%). Finally, reporting current injection drug use (aOR, 0.6; 95% CI, 0.4% to 0.9%) was inversely related to discordance. Conclusions The inconsistent association between condom use and BV found in prior studies could be the result of participant reporting bias. The present study found evidence of a relationship between semen exposure and incident BV. Also, given the number and range of correlates of discordance between self-reported and biological evidence of semen exposure, inaccuracies in the reporting of sexual behaviours cannot be assumed to be distributed randomly across a study population. 
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